MICHAEL ODO, MSc, MPH, PhD

INSTRUCTOR, HEALTH SYSTEMS MANAGEMENT

  • LinkedIn
  • Facebook
  • Twitter

Office Address:  AM Dogliotti Medical School Campus, Catholic Junction, Monrovia

Biography

Dr. Michael Odo is a passionate Public Health Specialist with MB; BCH and MSc degrees from Nigeria and an MPH from the University of Liverpool, UK. Formerly a Technical Advisor with the University of Washington (I-TECH) and currently FHI360`s Senior Technical Advisor to the NACP, Liberia. Michael has 16+ years of working experience leading in project designing, planning, budgeting, implementation, management, supervision and monitoring and evaluation in multiple sub-Saharan African countries (Nigeria, Malawi, Ghana, Liberia, South Africa, Eswatini), with hands-on quality improvement experience in treatment and prevention of HIV and TB, including treatment sequencing for drug resistant strains. Michael has been a Project management team lead for the development and implementation of strategies, operational plan and budgets to high professional standard to fulfil donor and organizational requirements, including the CDC Human Resource for Health award in the Republic of Malawi, the $450 million PEPFAR country-wide GHAIN project and the $350 million follow-on SIDHAS project in Nigeria implemented by FHI360. He is an active member of WHO Technical Working Groups, international learning networks, including the BMGF-supported and ICAP-implemented Coverage, Quality and Impact Network (CQUIN) for 14 African Countries, International Union Against TB and Lung Disease and the International AIDS Society. He is also a Co-investigator of several ongoing implementation sciences. Michael is formerly a lecturer at the College of Medical Sciences of the University of Calabar and MPH Dissertation supervisor for Texila American University, Guyana.

QUALIFICATION

MB;BCH - University of Calabar (1997)

MSc - University of Calabar (2005)

MPH - University of Liverpool (2013)

PhD - Texila American University

CURRENT ENGAGEMENT 

HSMT604, QMIS (Quality Improvement and Implementation Science)

Image by 🇸🇮 Janko Ferlič

PUBLICATIONS

  1. Odo, M., Obeagu, E. I., Ochei, K. C., Nkombe E., Olusola-Faleye, B., Effa, E., Affirima, B. (2016) Intensified TB case finding in PMTCT settings in Nigeria should be reconsidered. International Journal of Advanced Research in Biological Sciences. 3(2): 85-92. ISSN: 2348-8069.

  2. Michael Odo., Kingsley Chinedum Ochei., Emmanuel Ifeanyi Obeagu., Afirima barinaadaa., Ugobo Emmanuel Eteng., Mabel Ikpeme., Jonah Offor Bassey (2020) TB Infection Control in TB/HIV Settings in Cross River State, Nigeria: Policy Vs Practice. Journal of Pharmaceutical research International, 32(22) 101-109. ISSN: 2456-9119

  3. Michael Odo., Kingsley Chinedum Ochei., Emmanuel Ifeanyi Obeagu., Afirima Barinaadaa., Emmanuel Ugobo Eteng., Mabel Ikpeme., Jonah Offor Bassey., Andrew Ogar Paul (2020)Cascade Variabilities in TB Case Finding among People Living with HIV and the Use of IPT: Assessment in Three Levels of Care in Cross River State, Nigeria. 32(24): 9-18. Article No. JPRI. 61152.

  4. Michael Odo; Sunday Olarewaju; Edward Oladele; Oluwasanmi Adedokun; Obinna Ogbanufe; Solomon Odafe; Hadiza Khamofu, Kwasi Torpey. Comparison of Immune Recovery among HIV and TB/HIV Co-infected patients on antiretroviral therapy in Nigeria. Accepted and presented at the International Union Conference on Lung Health, Kwala Lumpur, Malaysia, 2013.

  5. Michael Odo; Flora Nwagbo; Sunday Olarewaju; Joachim Okhifo; Hadiza Khamofu; Joshua Obasanya; Kwasi Torpey (2013) Innovative Approaches to Establishing and Sustaining a Drug Resistant Tuberculosis In-patient facility in a secondary level hospital in Lagos- Nigeria. Accepted and presented at the International Union Conference on Lung Health, Kwala Lumpur, Malaysia, 2013.

  6. Enerst Afu Ochang., Ubleni E. Emanghe., Atana Ewa., Akaniyene Out., Jonah B. Offor., Aniekan Etokidem., Barinaadaa Afirima., Oju Eni Owuna., Sunday M. Obeten., Michael Odo., Martin M. Meremikwu (2017) Evaluation of Pulmonary Tuberculosis Case Detection Improvement with the Deployment of Xpert MTB/Rif in the Tuberculosis Control Program of Cross River State, Nigeria. The International Journal of Mycobacteriology. Volume 6. Issue 1. January-March, 2017. (www.ijmyco.org)

  7. Akolo C., Bada, F., Okpokoro, E., Nwanne, E., Iziduh, S., Usoroh, E., Ali, T., Ibeziako, V., Oladimeji, O., Odo, M. O (2015) Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons. World Journal of Virology 2015, May 12; 4(2)105-112. ISSN 2220-3249.

  8. Olusola-Faleye, B., Obeagu, E. I., Odo, M., Ochei, K. C., Solanke, E., Idaboh, T. (2016) Impact of community based tuberculosis care interventions on TB case detection in Nigeria – what works and what does not? International Journal of advanced multidisciplinary Research. 3(2) 30-39. ISSN: 2393-8870

  9. Chukwuemeka Anoje., Bolatito Aiyenigba., Chiho Suzuki., Titilope Badru., Kesiena Akpoigbe., Michael Odo., Solomon Odafe., Oluwasanmi Adedokun., Kwasi Torpey., Otto N Chabikuli. (2012) Reducing Mother-To-Child Transmission of HIV: Findings from an Early Infant Diagnosis Program in South-South region of Nigeria. BMC Pub Health, 12:184. Available hhtp://www.biomedcentral.com1471-2458/12/184

  10. Offor, I. B., Obeagu, E. I., Ochei, K. C., Odo, M. (2016) Evaluation of Lipids and protein profiles in Tuberculosis Patients on anti-TB therapy in General Hospital, Umuguma, Owerri. International Journal of Current Research in Chemistry and Pharmaceutical Sciences. 3(2) 20-28. ISSN: 2348-5221.

Research 

A multipronged strategy to improve viral load testing coverage in Liberia; Enhanced monitoring of DTG-containing regimen replacing 1st line ART in Chiradzulu District, Malawi`; Determining Risk Factors for Pellagra During the Isoniazid Preventive Therapy Scale-Up in Malawi` and Validation of a screening tool used to identify children living with HIV in high volume outpatient departments in Malawi.

RESEARCH INTERESTS

TB and HIV

Quality Improvement and Implementation Science

Treatment Outcomes

RESEARCH METHODS

Sample size Calculation

Survey development

Retrospective studies of routine programs